Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—N.D. Cal.: Baby food MDL is dismissed for lack of federal jurisdiction
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Medicare reactivation effective date tied to receipt of approved revalidation application
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—FINAL RULES: DEA revokes exempted status for inactive butalbital products
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ELECTRONIC HEALTH RECORDS—W.D. Ky.: Humana privacy lawsuit advances over alleged tracking of health information
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—FDA opens applications for new pilot to shorten drug approval times: What sponsors need to know
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FOOD SAFETY—FDA GUIDANCE NOTICES: FDA issues draft guidance on requirements for food traceability records
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: FDA classifies cell enrichment kit
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PREEMPTION OF STATE LAW—1st Cir.: Seizure patient’s estate may amend complaint against Amgen about Aimovig biologic labeling
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • RURAL HEALTH CLINICS—GAO REPORTS: CMS awarded states $10 billion in RHT program funding
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—FINAL RULES: DEA revokes exempted status for inactive butalbital products, (Oct 15, 2026)

    By WK Editorial Staff

    The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on the DEA’s Table of Exempted Prescription Products.

    The certain nonnarcotic prescription productsȁ ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use